{"chunk_id": "medquad__chunk_43134", "source": "medquad", "text": "cts are then released in urine. The fibronectin-1 deposits impair the glomeruli's filtration ability.  Fifteen to 20 years following the appearance of signs and symptoms, individuals with fibronectin glomerulopathy often develop end-stage renal disease. Affected individuals may receive treatment in the form of a kidney transplant; in some cases, fibronectin glomerulopathy comes back (recurs) following transplantation.\",GHR,fibronectin glomerulopathy\nHow many people are affected by fibronectin gl"}